New study links genetic variation to chemotherapy-related liver damage in patients with colorectal cancer liver metastases - EurekAlert!
How does chemotherapy disrupt circadian rhythms? - EurekAlert!
Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC - EurekAlert!
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy - EurekAlert!
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study - EurekAlert!
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC - EurekAlert!
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC - EurekAlert!
New cancer drug boosts effectiveness of chemotherapy – even in resistant tumours - EurekAlert!
Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients - EurekAlert!
Supercharging chemotherapy: how mitochondria fuel anti-tumor defense - EurekAlert!
Study: Powerlifting through breast cancer – how a breast cancer survivor defied chemotherapy with strength trainin - EurekAlert!
Exercise during chemotherapy may help immune cells fight cancer – patients invited to join new trial - EurekAlert!
Five-year analysis shows immunotherapy plus chemotherapy before lung cancer surgery significantly improves long-term survival - EurekAlert!
Immunotherapy boosts chemotherapy in combating stage 3 colon cancer - EurekAlert!
Alliance presents results from phase III ATOMIC trial combining atezolizumab with chemotherapy for patients with stage III dMMR colon cancer at ASCO 2025 - EurekAlert!
First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer - EurekAlert!
Medical marijuana could increase efficacy of chemotherapy to fight cancer while reducing side effects, study suggests
DiffInvex reveals how cancers rewire driver genes to beat chemotherapy - EurekAlert!
FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy
Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer
